Letter Sequence Request |
---|
EPID:L-2017-PMP-0014, Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 (Open) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017 Irrevocable Standby Letter of Credit (Redacted) Project stage: Request ML18054A0772018-03-0808 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18092A0872018-03-27027 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18087A3892018-03-28028 March 2018 Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC Project stage: Request ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018 Shine Medical Technologies, Inc. April 3, 2018 Public Meeting Project stage: Request ML18096A6882018-04-0303 April 2018 Confirmatory Action Letter (CAL) No. NRR-2011-001 Project stage: Request ML18096A4552018-04-0303 April 2018 Shine Operating License Pre-Application Meeting (Environmental Presentation Slides) Project stage: Request ML18087A3402018-04-0303 April 2018 Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18096A6892018-04-0303 April 2018 Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations Project stage: Request ML18130A5782018-05-0707 May 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18162A1362018-05-11011 May 2018, 18 June 2018 Shine Medical Technologies, Inc. May 23, 2018 Public Meeting Project stage: Request ML18138A2912018-05-16016 May 2018 Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC Project stage: Request ML18128A0342018-05-16016 May 2018 Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18156A1302018-06-0101 June 2018 Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18155A6032018-06-0707 June 2018 Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18162A1172018-06-18018 June 2018 Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report Project stage: Other ML18162A0552018-06-18018 June 2018 Shine Medical Technologies April 3, 2018 Public Meeting Summary Project stage: Meeting ML18162A1162018-06-18018 June 2018 Shine Medical Technologies Annual Financial Report Project stage: Request ML18162A1182018-06-18018 June 2018 Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report Project stage: Other ML18162A1292018-06-18018 June 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions Project stage: Other ML18162A1382018-06-18018 June 2018 May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc Project stage: Meeting ML18127B7062018-06-21021 June 2018 Closure of NRC Confirmatory Action Letter No. NRR-2011-001 Project stage: Other ML18221A4532018-06-27027 June 2018, 17 August 2018 Shine Medical Technologies, Inc. June 2018 Public Meeting Project stage: Request ML18187A2162018-07-0202 July 2018 Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML18197A0802018-07-10010 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18193A1412018-07-16016 July 2018 Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18277A1962018-07-17017 July 2018 Amendment to Standby Letter of Credit (Redacted) Project stage: Request ML18206A7262018-07-18018 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted) Project stage: Request ML18221A4542018-08-17017 August 2018 Summary of Meeting with Shine Medical Technologies, Inc. Project stage: Meeting ML18239A2192018-08-27027 August 2018 Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility Project stage: Request ML18268A3442018-10-0202 October 2018 Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014 Project stage: Other ML18340A1712018-12-10010 December 2018 Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions Project stage: Other ML18340A2762018-12-19019 December 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements Project stage: Other ML19025A2642019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML19025A2752019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19015A3522019-02-15015 February 2019 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML19071A1852019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure Project stage: Other ML19071A1812019-03-22022 March 2019 Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary Project stage: Meeting ML19071A1792019-03-22022 March 2019 Shine Medical Technologies, Inc. January 31, 2019 Public Meeting Project stage: Request ML19071A1802019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance 2018-06-18
[Table View] |
|
---|
Category:Slides and Viewgraphs
MONTHYEARML22166A0442022-05-11011 May 2022 Shine Technologies, LLC May 11, 2022 Cybersecurity Public Meeting Presentation ML22110A2092022-01-20020 January 2022 Shine Slides - Phased Approach Supplement (Open Session) ML21105A5882021-04-15015 April 2021 Enclosure 2 - Meeting Slides from the April 13, 2021 Public Meeting Between Shine Medical Technologies, LLC and the NRC Phased Approach to Initial Operations of the Shine Facility ML21105A5902021-04-15015 April 2021 Enclosure 4 - Meeting Slides from the April 13, 2021 Public Meeting Between Shine Medical Technologies, LLC and the NRC Possession-Only License Amendment Request ML20069B1542020-02-24024 February 2020 Enclosure 2 - Tritium Purification System Design Change - Public Version ML20069B1572020-02-24024 February 2020 Enclosure 4 - Shine Safety Analysis Methodology - Public Version ML20069B1592020-02-24024 February 2020 Enclosure 6 - Shine Safety Analysis Approach - Public Version ML19339E7162019-12-0404 December 2019 Enclosure 2 - Meeting Slides Re Shine Overview (Public Version) ML19339E7172019-12-0404 December 2019 Enclosure 4 - Meeting Slides Re Shine Instrumentation and Control Systems (Public Version) ML19339E7192019-12-0404 December 2019 Enclosure 6 - Meeting Slides Re Shine Accident Analysis Overview (Public Version) ML19025A2672019-01-22022 January 2019 Enclosure 6 - Meeting Slides for the January 29 and 30, 2019 Meeting Between Shine Medical Technologies, Inc. and the NRC - Shine Identification of Safety-Related Controls ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC ML19025A2652019-01-22022 January 2019 Enclosure 2 - Meeting Slides for the January 29 and 30, 2019 Meeting Between Shine Medical Technologies, Inc. and the NRC - Shine Technology Overview ML19025A2662019-01-22022 January 2019 Enclosure 4 - Meeting Slides for the January 29 and 30, 2019 Meeting Between Shine Medical Technologies, Inc. and the NRC - Shine Construction Planning ML18187A2162018-07-0202 July 2018 Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC ML18173A1372018-06-20020 June 2018 Meeting Slides for the June 28, 2018 Public Meeting Between Shine Medical Technologies, Inc. and the NRC ML18169A4112018-06-20020 June 2018 American Nuclear Society 2018 Annual Meeting: U.S. Nuclear Regulatory Commission Activities Related to Domestic Molybdenum-99 Production ML18138A2912018-05-16016 May 2018 Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC ML18096A4552018-04-0303 April 2018 Shine Operating License Pre-Application Meeting (Environmental Presentation Slides) ML18087A3892018-03-28028 March 2018 Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC ML16327A1832016-11-22022 November 2016 Slides for 12/01/2016 Public Meeting with Shine Medical Technologies, Inc. to Discuss Shine'S Evaluation of Potential Structures of the Operating License and Planned Design Changes ML16215A4092016-05-26026 May 2016 05/26/2016 - Eligible Facilities List Presentation for SHINE Medical Technologies Public Meeting ML16215A4102016-05-26026 May 2016 05/26/2016 - Non-Power Production and Utilization Facility Construction Inspection Program Presentation ML16139A5932016-05-18018 May 2016 Meeting Slides for the May 26, 2016 Public Meeting Between Shine Medical Technologies, Inc., and the NRC ML15153A1752015-06-10010 June 2015 Slides for the Public Meeting on the Shine Draft Environmental Impact Statement ML14070A2362014-03-0505 March 2014 Enclosure 2 - 03/19/2014 Meeting Slides - Shine Medical Technologies, Inc., Proposed Facility Design Changes and Impact on the PSAR (Public Version) and Enclosure 3 - Affidavits ML13190A4192013-07-17017 July 2013 Shine Medical Technologies, Inc. - Construction Permit Review Process and Environmental Scoping Meeting 2022-05-11
[Table view] |
Text
Pre-application Meeting Regarding the SHINE Medical Technologies Operating License Application: EnvironmentalOffice of Nuclear Reactor RegulationU.S. Nuclear Regulatory CommissionApril 3, 2018 Agenda*Regulatory background
- Consideration of new information
- Format2 Regulatory Background
- 10 CFR 51.95 (b) requires the NRC staff to prepare a supplemental environmental impact statement (EIS)
- The supplemental EIS will:
- update the prior staff review for the construction permit
- describe matters that differ or that reflect significant new information since publication of the final EIS
- The supplemental EIS does not need to include:*a discussion of matters that are the same or that have not changed since publication of the final EIS 3
Regulatory Background
- 10 CFR 51.53(b) requires an applicant to prepare an environmental report*The environmental report should:
- discuss matters that differ or that reflect new information since publication of the final EIS*The environmental report does not need to include:*a discussion of matters that are the same or that have not changed 4
Consideration of New or Different Information
- The applicant should consider all matters described in: *10 CFR 51.45, 51.51, and 51.52*Interim Staff Guidance Augmenting NUREG
-1537, Chapter 19, "Environmental Report."
- The level of detail for each new or different matter should:
- be similar to the level of detail in the construction permit final EIS
- be commensurate with the likelihood of impacts, especially in situations where new or different information could lead to a different conclusion 5
Consideration of New or Different Information
- Changes to the facility design that could affect the environment, for example:
- construction activities that could affect operations or decommissioning
- Changes to facility operation that could affect the environment, for example:
- new or revised production activities that could change air emissions or dose exposures 6
Consideration of New or Different Information
- Changes to the natural or physical environment, for example:
- clearing or grading on site
- new activities or facilities surrounding the site
- threatened or endangered species listed or new cultural resource identified since publication of the final EIS
- change in air quality designation
- Changes to the regulatory environment, for example:
- new air quality regulations issued
- New environmental information or studies, for example:
- new environmental studies conducted by the applicant or another organization 7
Best Practices
-application meetings with the NRC staff
- If no change has occurred, provide a brief basis for that conclusion, such as:
- no new regulations published
- no change to the building design
- no change in the physical or natural environment on and surrounding the site
- Include copies of correspondence with any Federal, State, or local agencies since publication of the final EIS8 Format*Length of environmental report and supplemental EIS commensurate with the number and extent of changes.
- Following a similar format of the previous environmental report may help to ensure completeness, consistency, and accuracy.9 Discussion